1-8 of 8
Alan B. Sandler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase III Clinical Trial Development: A Process of Chutes and Ladders

David M. Dilts, Steven K. Cheng, Joshua S. Crites, Alan B. Sandler, James H. Doroshow
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (22): 5381–5389.
https://doi.org/10.1158/1078-0432.CCR-10-1273
Published: 14 November 2010
View article titled, Phase III Clinical Trial Development: A Process of Chutes and Ladders
Open the PDF for Phase III Clinical Trial Development: A Process of Chutes and Ladders in another window
Journal Articles

A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer

Robert Mutter, Bo Lu, David P. Carbone, Ildiko Csiki, Luigi Moretti, David H. Johnson, Jason D. Morrow, Alan B. Sandler, Yu Shyr, Fei Ye, Hak Choy
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2158–2165.
https://doi.org/10.1158/1078-0432.CCR-08-0629
Published: 16 March 2009
View article titled, A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer
Open the PDF for A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer in another window
Journal Articles

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

Lia Gore, Mace L. Rothenberg, Cindy L. O'Bryant, Mary Kay Schultz, Alan B. Sandler, Denise Coffin, Candice McCoy, Astrid Schott, Catherine Scholz, S. Gail Eckhardt
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4517–4525.
https://doi.org/10.1158/1078-0432.CCR-07-1461
Published: 15 July 2008
View article titled, A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas
Open the PDF for A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas in another window
Journal Articles

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study

Afshin Dowlati, Robert Gray, Alan B. Sandler, Joan H. Schiller, David H. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1407–1412.
https://doi.org/10.1158/1078-0432.CCR-07-1154
Published: 03 March 2008
View article titled, Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
Open the PDF for Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study in another window
Includes: Supplementary data
Journal Articles

Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference

Thomas J. Lynch, Philip D. Bonomi, Charles Butts, Angela M. Davies, Jeffrey Engelman, Ramaswamy Govindan, Roy S. Herbst, John V. Heymach, Bruce E. Johnson, Renato G. Martins, Roman Perez-Soler, Gregory J. Riely, Alan B. Sandler, Lecia V. Sequist, Mark A. Socinski, Kwok-Kin Wong, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4583s–4588s.
https://doi.org/10.1158/1078-0432.CCR-07-0716
Published: 01 August 2007
View article titled, Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference
Open the PDF for Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference in another window
Journal Articles

Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents

Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Jr., Tim G. Eisen, Jeffrey Engelman, Glenwood D. Goss, Daniel A. Haber, John V. Heymach, Pasi A. Jänne, Bruce E. Johnson, David H. Johnson, Rogerio C. Lilenbaum, Matthew Meyerson, Alan B. Sandler, Lecia V. Sequist, Jeffrey Settleman, Kwok-Kin Wong, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4365s–4371s.
https://doi.org/10.1158/1078-0432.CCR-06-1005
Published: 20 July 2006
View article titled, Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents
Open the PDF for Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents in another window
Journal Articles

Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement

Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Jr., Raymond N. DuBois, David R. Gandara, Giuseppe Giaccone, Ramaswamy Govindan, Roy S. Herbst, Bruce E. Johnson, Fadlo R. Khuri, Roman Perez-Soler, Rafael Rosell, Eric K. Rowinsky, Alan B. Sandler, Giorgio V. Scagliotti, Joan H. Schiller, Geoffrey I. Shapiro, Mark A. Socinski, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4199s–4204s.
https://doi.org/10.1158/1078-0432.CCR-040021
Published: 15 June 2004
View article titled, Novel Agents in the Treatment of Lung Cancer: <subtitle>Conference Summary Statement</subtitle>
Open the PDF for Novel Agents in the Treatment of Lung Cancer: <subtitle>Conference Summary Statement</subtitle> in another window
Journal Articles

Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer

Alan B. Sandler, David H. Johnson, Roy S. Herbst
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4258s–4262s.
https://doi.org/10.1158/1078-0432.CCR-040023
Published: 15 June 2004
View article titled, Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer
Open the PDF for Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer in another window